| Long-term outcome of renal transplantation from older donors G Remuzzi, P Cravedi, A Perna, BD Dimitrov, M Turturro, G Locatelli, ... New England Journal of Medicine 354 (4), 343-352, 2006 | 581 | 2006 |
| COVID‐19 and kidney transplantation: results from the TANGO International Transplant Consortium P Cravedi, SS Mothi, Y Azzi, M Haverly, SS Farouk, MJ Pérez‐Sáez, ... American Journal of Transplantation 20 (11), 3140-3148, 2020 | 429 | 2020 |
| The RAAS in the pathogenesis and treatment of diabetic nephropathy P Ruggenenti, P Cravedi, G Remuzzi Nature Reviews Nephrology 6 (6), 319-330, 2010 | 378 | 2010 |
| Rituximab in idiopathic membranous nephropathy P Ruggenenti, P Cravedi, A Chianca, A Perna, B Ruggiero, F Gaspari, ... Journal of the American Society of Nephrology 23 (8), 1416-1425, 2012 | 355 | 2012 |
| Dietary intake regulates the circulating inflammatory monocyte pool S Jordan, N Tung, M Casanova-Acebes, C Chang, C Cantoni, D Zhang, ... Cell 178 (5), 1102-1114. e17, 2019 | 342 | 2019 |
| Mechanisms and treatment of CKD P Ruggenenti, P Cravedi, G Remuzzi Journal of the American Society of Nephrology 23 (12), 1917-1928, 2012 | 330 | 2012 |
| Regulatory T cells and T cell depletion: role of immunosuppressive drugs M Noris, F Casiraghi, M Todeschini, P Cravedi, D Cugini, G Monteferrante, ... Journal of the American Society of Nephrology 18 (3), 1007-1018, 2007 | 287 | 2007 |
| Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease P Cravedi, G Remuzzi British journal of clinical pharmacology 76 (4), 516-523, 2013 | 248 | 2013 |
| Role of remission clinics in the longitudinal treatment of CKD P Ruggenenti, E Perticucci, P Cravedi, V Gambara, M Costantini, ... Journal of the American Society of Nephrology 19 (6), 1213-1224, 2008 | 244 | 2008 |
| Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response LL Cunha, SF Perazzio, J Azzi, P Cravedi, LV Riella Frontiers in immunology 11, 1748, 2020 | 238 | 2020 |
| COVID-19 in kidney transplant recipients I Gandolfini, M Delsante, E Fiaccadori, G Zaza, L Manenti, A Degli Antoni, ... American Journal of Transplantation 20 (7), 1941-1943, 2020 | 238 | 2020 |
| Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome P Ruggenenti, B Ruggiero, P Cravedi, M Vivarelli, L Massella, M Marasà, ... Journal of the American Society of Nephrology 25 (4), 850-863, 2014 | 233 | 2014 |
| Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy P Cravedi, P Ruggenenti, MC Sghirlanzoni, G Remuzzi Clinical Journal of the American Society of Nephrology 2 (5), 932-937, 2007 | 215 | 2007 |
| A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier A Petrosyan, P Cravedi, V Villani, A Angeletti, J Manrique, A Renieri, ... Nature communications 10 (1), 3656, 2019 | 186 | 2019 |
| COVID-19 and the kidney: what we think we know so far and what we don’t SS Farouk, E Fiaccadori, P Cravedi, KN Campbell Journal of nephrology 33 (6), 1213-1218, 2020 | 168 | 2020 |
| Proteinuria should be used as a surrogate in CKD P Cravedi, P Ruggenenti, G Remuzzi Nature reviews Nephrology 8 (5), 301-306, 2012 | 151 | 2012 |
| The Kidney Donor Profile Index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes I Gandolfini, C Buzio, P Zanelli, A Palmisano, E Cremaschi, A Vaglio, ... American Journal of Transplantation 14 (11), 2515-2525, 2014 | 143 | 2014 |
| Immune cell-derived C3a and C5a costimulate human T cell alloimmunity P Cravedi, J Leventhal, P Lakhani, SC Ward, MJ Donovan, PS Heeger American Journal of Transplantation 13 (10), 2530-2539, 2013 | 142 | 2013 |
| The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas A Peloso, L Urbani, P Cravedi, R Katari, P Maghsoudlou, MEA Fallas, ... Annals of surgery 264 (1), 169-179, 2016 | 141 | 2016 |
| Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial G Remuzzi, P Cravedi, M Costantini, M Lesti, M Ganeva, G Gherardi, ... Journal of the American Society of Nephrology 18 (6), 1973-1985, 2007 | 138 | 2007 |
